Published on November 9, 2023, 4:10 am
Zuellig Pharma Digital & Data has recently unveiled the Digital Health Exchange (DHEX), marking the inception of the first regional healthcare data consortium in Asia that is powered by Privacy Enhancing Technologies (PET) and Confidential Computing. This groundbreaking initiative, which falls under the PET Sandbox program administered by Infocomm Media Development Authority (IMDA), aims to connect data partners with data consumers in order to expedite seamless access to actionable healthcare insights and intelligence.
The launch of DHEX represents a significant step towards achieving data democratization and spurring innovation in healthcare across Asia. By leveraging PETs, Zuellig Pharma and its clients can leverage external data sources to enhance their market strategies for new pharmaceutical products while ensuring the protection of patient data.
John Graham, CEO of Zuellig Pharma, expressed his appreciation for the PET Sandbox initiative, stating that it not only provides a secure and compliant platform for players in the healthcare industry to drive innovation but also enables solutions that enhance accessibility to healthcare services.
Lew Chuen Hong, chief executive of IMDA, welcomed Zuellig Pharma’s participation in the PET Sandbox program. He highlighted how PETs enable businesses to access data and derive new insights or develop AI products while ensuring trust. Chew pointed out that this technology empowers Zuellig Pharma and its clients to innovate with data while safeguarding consumer privacy, both important aspects of nurturing a thriving digital economy.
DHEX fills a critical gap in Asia’s healthcare landscape as there was no existing platform dedicated solely to healthcare data. The consortium aims to address challenges faced by both data partners and consumers such as fragmented silos of information, technological limitations, varied levels of tech maturity, development disparities, and a lack of trust.
Daniel Laverick, chief digital and data officer at Zuellig Pharma, emphasized that DHEX seeks to redefine how businesses access comprehensive data assets, expertise, and technologies to deliver commercial excellence, market access excellence, and medical excellence in a nimble and agile manner. Through the PET Sandbox initiative, Zuellig Pharma Digital & Data envisions establishing standards and best practices for broader PET adoption.
By leveraging PETs, DHEX aims to democratize data by harnessing the value of data from partners, including healthcare providers and Zuellig Pharma itself, across 13 markets. These advanced analytics capabilities will foster a secure collaborative ecosystem that prioritizes data-centric excellence while adhering to strict compliance with data privacy and competition laws.
Michael Andrew, head of data analytics at Zuellig Pharma, highlighted the significance of adopting PETs within the healthcare sector. By protecting personal data and commercially sensitive information while still allowing businesses to derive value from their datasets, this technology facilitates secure B2B data collaboration through flexible partnership models. It also enables encrypted transfer and cross-border data flows, thereby providing curated datasets or aggregated insights that help users connect the dots in their analytics journey.
The launch of DHEX represents a milestone achievement in Asia’s healthcare industry by bringing together key stakeholders to unlock the potential of healthcare data in a secure and compliant manner. By enabling streamlined access to actionable insights and fostering collaboration among players in the healthcare space, DHEX holds great promise for driving innovation and improving healthcare outcomes throughout the region.